Skip to main content
PMC home page
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 Oct;76(10):621–623. doi: 10.1136/bjo.76.10.621

AgNOR counts in conjunctival malignant melanoma lack prognostic value.

A D Paridaens 1, S Seregard 1, D Minassian 1, J L Hungerford 1, A C McCartney 1
PMCID: PMC505239  PMID: 1420045

Abstract

Using a silver staining technique, argyrophilic nucleolar organiser region-associated proteins (AgNORs) have been studied in routinely processed paraffin sections of 46 invasive malignant melanomas (MM) of the conjunctiva. The aim of this retrospective study was to assess the value of the AgNOR method as a prognostic indicator for this neoplasm. The 46 cases were divided into two groups: (A) 14 cases of MM that metastasised and caused death of the patient within 5 years of (histological) diagnosis, and (B) 32 cases of MM that did not metastasise and in which patients survived beyond 5 years. The mean of the AgNOR counts per nucleus was 7.03 (95% CI: 5.81-8.24) in group A, and 7.15 (95% CI: 6.53-7.77) in group B. A comparison using a multifactor analysis of variance (ANOVA) model, which corrected for possible confounding effect of tumour thickness, site, and cell type showed no significant difference in AgNOR counts between groups A and B (p = 0.8). Analysis by the Cox proportional hazards regression model showed that survival was not influenced significantly by the mean AgNOR number (hazard ratio: 0.92). Whereas the AgNOR technique may be used to distinguish benign from malignant melanocytic lesions of the conjunctiva, we conclude it has no value in predicting the outcome for patients with conjunctival MM.

Full text

PDF
621

Images in this article

622Image
on p.622

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crawford J. B. Conjunctival melanomas: prognostic factors a review and an analysis of a series. Trans Am Ophthalmol Soc. 1980;78:467–502. [PMC free article] [PubMed] [Google Scholar]
  2. Crocker J., Nar P. Nucleolar organizer regions in lymphomas. J Pathol. 1987 Feb;151(2):111–118. doi: 10.1002/path.1711510203. [DOI] [PubMed] [Google Scholar]
  3. Crocker J., Skilbeck N. Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study. J Clin Pathol. 1987 Aug;40(8):885–889. doi: 10.1136/jcp.40.8.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Deuble K., McCartney A. Nucleolar organiser regions in iris melanocytic tumours: an accurate predictor? Eye (Lond) 1990;4(Pt 5):743–750. doi: 10.1038/eye.1990.106. [DOI] [PubMed] [Google Scholar]
  5. Folberg R., McLean I. W., Zimmerman L. E. Malignant melanoma of the conjunctiva. Hum Pathol. 1985 Feb;16(2):136–143. doi: 10.1016/s0046-8177(85)80062-9. [DOI] [PubMed] [Google Scholar]
  6. Howat A. J., Giri D. D., Wright A. L., Underwood J. C. Silver-stained nucleoli and nucleolar organizer region counts are of no prognostic value in thick cutaneous malignant melanoma. J Pathol. 1988 Nov;156(3):227–232. doi: 10.1002/path.1711560307. [DOI] [PubMed] [Google Scholar]
  7. JAY B. NAEVI AND MELANOMATA OF THE CONJUNCTIVA. Br J Ophthalmol. 1965 Apr;49:169–204. doi: 10.1136/bjo.49.4.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jeffrey I. J., Lucas D. R., McEwan C., Lee W. R. Malignant melanoma of the conjunctiva. Histopathology. 1986 Apr;10(4):363–378. doi: 10.1111/j.1365-2559.1986.tb02490.x. [DOI] [PubMed] [Google Scholar]
  9. Leong A. S., Gilham P. Silver staining of nucleolar organizer regions in malignant melanoma and melanotic nevi. Hum Pathol. 1989 Mar;20(3):257–262. doi: 10.1016/0046-8177(89)90133-0. [DOI] [PubMed] [Google Scholar]
  10. Marcus D. M., Minkovitz J. B., Wardwell S. D., Albert D. M. The value of nucleolar organizer regions in uveal melanoma. The Collaborative Ocular Melanoma Study Group. Am J Ophthalmol. 1990 Nov 15;110(5):527–534. doi: 10.1016/s0002-9394(14)77877-8. [DOI] [PubMed] [Google Scholar]
  11. Orrell J. M., Evans A. T., Grant A. A critical evaluation of AgNOR counting in benign naevi and malignant melanoma. J Pathol. 1991 Mar;163(3):239–244. doi: 10.1002/path.1711630309. [DOI] [PubMed] [Google Scholar]
  12. Ploton D., Menager M., Jeannesson P., Himber G., Pigeon F., Adnet J. J. Improvement in the staining and in the visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J. 1986 Jan;18(1):5–14. doi: 10.1007/BF01676192. [DOI] [PubMed] [Google Scholar]
  13. Sivridis E., Sims B. Nucleolar organiser regions: new prognostic variable in breast carcinomas. J Clin Pathol. 1990 May;43(5):390–392. doi: 10.1136/jcp.43.5.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. The nucleolar organizer regions. Biol Cell. 1983;49(3):191–202. [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES